Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 7

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 7
---
 to complete our initial business combination with a business that is affiliated with any of our initial shareholders
or members of our management team, we, or a committee of independent and disinterested directors, may engage independent advisors to assist
with the evaluation and will obtain an opinion from an independent investment banking firm that is a member of the Financial Industry
Regulatory Authority, or FINRA, or from an independent accounting firm, that such an initial business combination is fair to our company
from a financial point of view.

Our initial shareholders
and members of our management team directly or indirectly own our securities, and accordingly, they may have a conflict of interest in
determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
Further, each of our initial shareholders, officers and directors may have a conflict of interest with respect to evaluating a particular
business combination if the retention or resignation of any such initial shareholders, officers and directors was included by a target
business as a condition to any agreement with respect to our initial business combination.

4

Our initial shareholders
and members of our management team may from time to time become aware of potential business opportunities, one or more of which we may
desire to pursue as an initial business combination, but we have not (nor has anyone on our behalf) engaged in any substantive discussions,
directly or indirectly, with any business combination target with respect to a business combination transaction with us.

Each of our officers and
directors presently has, and any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one
or more other entities pursuant to which such officer or director may be required to present a business combination opportunity to such
entities. Our amended and restated memorandum and articles of association provide that, to the fullest extent permitted by applicable
law: (i) no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract,
to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we
renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which
may be a corporate opportunity for any director or officer, on the one hand, and us, on the other. Accordingly, if any of our officers
or directors becomes aware of a business combination opportunity which is suitable for one or more entities to which he or she has